Cell Medica raised €64M in a Series B round in Nov 2014. The company is based in London, UK. Investors in the round: Imperial Innovations Limited, Invesco Perpetual, Woodford Investment Management. Data as of 7 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
